Contact
Please use this form to send email to PR contact of this press release:
Press release Oncology Venture to test activity of its PARP inhibitor, 2X-121, as a potential therapy for Coronavirus
TO:
Please use this form to send email to PR contact of this press release:
Press release Oncology Venture to test activity of its PARP inhibitor, 2X-121, as a potential therapy for Coronavirus
TO: